Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2875 studies found for:    paclitaxel
Show Display Options
Rank Status Study
1 Recruiting Study to Evaluate CORT125134 in Combination With Nab-paclitaxel in Patients With Solid Tumors
Conditions: Solid Tumors;   Cellular Diagnosis, Ovarian Epithelial Cancer;   Breast Cancer
Intervention: Drug: CORT125134 with nab-paclitaxel
2 Recruiting To Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors
Conditions: Neuroblastoma;;   Rhabdomyosarcoma;;   Ewing's Sarcoma;;   Ewing's Tumor;;   Sarcoma, Ewing's;;   Sarcomas, Epitheliod;;   Sarcoma, Soft Tissue;;   Sarcoma, Spindle Cell;;   Melanoma;;   Malignant Melanoma;;   Clinical Oncology;;   Oncology, Medical;;   Pediatrics, Osteosarcoma;;   Osteogenic Sarcoma;;   Osteosarcoma Tumor;;   Sarcoma, Osteogenic;;   Tumors;;   Cancer;;   Neoplasia;;   Neoplasm;;   Histiocytoma;;   Fibrosarcoma;;   Dermatofibrosarcoma
Intervention: Drug: nab-paclitaxel
3 Unknown  Phase I & II Trial of Intravesicular Abraxane for Treatment-refractory Bladder Cancer
Condition: Bladder Cancer
Intervention: Drug: Paclitaxel, nanoparticle albumin-bound
4 Active, not recruiting Schedules of Nab-Paclitaxel in Metastatic Breast Cancer
Condition: Metastatic Breastcancer
Intervention: Drug: nab-Paclitaxel
5 Recruiting A Phase I Trial of the Combination of AZD2014 and Weekly Paclitaxel.
Condition: Advanced Cancer
Interventions: Drug: AZD2014 3 on/4 off & weekly paclitaxel;   Drug: AZD2014 2 on/5 off & weekly paclitaxel
6 Active, not recruiting Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto)
Conditions: Tubular Breast Cancer Stage II;   Mucinous Breast Cancer Stage II;   Breast Cancer Female NOS;   Invasive Ductal Breast Cancer;   Tubular Breast Cancer Stage III;   HER-2 Positive Breast Cancer;   Inflammatory Breast Cancer Stage IV;   Inflammatory Breast Cancer
Interventions: Drug: nab-Paclitaxel;   Drug: Paclitaxel
7 Completed Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: Gemcitabine plus nab-paclitaxel
8 Unknown  Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer
Condition: Squamous Cell Carcinoma of Lung
Intervention: Drug: nanoparticle albumin-bound paclitaxel
9 Active, not recruiting Pembrolizumab and Paclitaxel in Refractory Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Intervention: Drug: pembrolizumab, paclitaxel
10 Recruiting A Study of CRLX101 in Combination With Weekly Paclitaxel in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Condition: Ovarian Cancer
Intervention: Drug: CRLX101 and weekly paclitaxel
11 Withdrawn Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of Esophagus
Condition: Squamous Cell Carcinoma of Esophagus
Intervention: Drug: nanoparticle albumin-bound paclitaxel
12 Completed Paclitaxel Administered by HAI to Patients With Advanced Cancer and Dominant Liver Involvement
Condition: Advanced Cancer
Intervention: Drug: Paclitaxel
13 Withdrawn A Randomized Study of Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Biological: Intraperitoneal tgDCC-E1A;   Drug: Paclitaxel
14 Unknown  Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional Treatments
Condition: Solid Tumors
Interventions: Drug: Paclitaxel liposome injection;   Drug: Paclitaxel injection
15 Active, not recruiting Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: defactinib (VS-6063);   Drug: Paclitaxel
16 Completed A Clinical Study in Cancer Patients to Investigate the Potential Impact of Custirsen, on the Blood Levels of the Chemotherapeutic Drug, Paclitaxel, When Given Together as Part of a Treatment Regimen
Condition: Cancer
Intervention: Drug: Custirsen, paclitaxel and carboplatin
17 Terminated Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Biological: Intraperitoneal tgDCC-E1A;   Drug: Paclitaxel
18 Unknown  The Efficacy and Safety of Nab-paclitaxel in Pretreated Patients With Extensive Disease of Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Intervention: Drug: Nab-paclitaxel
19 Active, not recruiting Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma
Condition: Resectable Pancreatic Adenocarcinoma
Interventions: Drug: LDE-225;   Drug: Gemcitabine;   Drug: nab-paclitaxel
20 Recruiting A Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Locally Recurrent or Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Intervention: Drug: Vantictumab combined with paclitaxel

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.